Delivery Order SPE2DB24D8003-SPE2DB25FJTLT

Award Date 12/13/24
Potential Completion Date 12/16/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTLT
    Delivery Order

This is a delivery order under a Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $1,867.25 and a period of performance through December 16, 2024. It is for the delivery of Dupixent 300 mg/2 mL syringes, a pharmaceutical product used for medical treatment. This award is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger IDC valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.

Generated 3/14/25, 9:59 AM